CareLit Fachartikel

Assessment of tumor response to antiangiogenic chemotherapy for hepatic breast cancer metastases: Imaging of the malignant neoangiogenesis with perfusion ct vs. contrast-enhanced…

S Savelli, S Pascoli, M Atzori, P Ialongo, G Regine, S Cisternino, LM Porfiri, L Adami · Ultraschall in der Medizin - European Journal of Ultrasound · 2007 · Heft 10

Dokument
1167648
CareLit-ID
Jahr
2007
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Ultraschall in der Medizin - European Journal of Ultrasound
Autor:innen
S Savelli, S Pascoli, M Atzori, P Ialongo, G Regine, S Cisternino, LM Porfiri, L Adami
Ausgabe
Heft 10 / 2007
Seiten
–
Erschienen: 2007-10-10 00:00:00
ISSN
0172-4614

Zusammenfassung

Objectives: Malignant angiogenesis affects tumor growth, local expansion and metastasis. Antiangiogenic chemotherapies act to reduce tumoral cell growth acting as angiogenesis inhibitor for endothelial cells. Objective tumor response is a common endpoint to evaluate the efficacy of anticancer agents. World Health Organization (WHO) or Response Evaluation Criteria in Solid Tumors Group (RECIST) criteria are not appropriate for the evaluation of targeted therapy because tumoral hypoxia is independent from tumor volume. The purpose of this study was to evaluate whether CEUS could be used to evaluate tumor response…

Schlagworte

Tumor Breast After Ultraschall in der Medizin - European Journal of Ultrasound